Site Search
Professionals 499 results
Capabilities 87 results
Practice Area
Class Actions & Group Litigation
Winston has developed a consistent record of success handling class action cases in state and federal courts. The practice is anchored by seasoned class action lawyers, many of whom have been recognized by Chambers USA and other ranking organizations as being top practitioners in their field. Our clients rely on us to steer them through class action matters by drawing on the firm’s significant experience in resolving complex litigation using creative and aggressive arguments, across a broad range of class, collective, coordinated, and mass actions, as well multidistrict litigation. We also have succeeded at trial in several class actions—a rare occurrence.
Practice Area
Our Labor & Employment Practice is one of the largest and most experienced practices among the country’s multi-disciplined law firms. Our attorneys represent global employers of all types and sizes—ranging from the Fortune 100 to privately held startups—often serving as national, regional, or preferred counsel to many of these major employers.
Practice Area
For decades, Winston has represented a broad array of clients in the insurance industry, including some of the world’s largest and best-known insurers. Our prowess in and understanding of the insurance industry encompasses not only its products, practices, and services, but also the increasing challenges posed by a world increasingly characterized by a fast-evolving technological landscape as well as financial, political, and environmental instability. Accordingly, Winston’s lawyers are among the most sought-after in the industry—not only by companies currently facing high-stakes litigations and investigations, but by those looking to take preventive action now in order to mitigate and manage their risk in the future.
Experience 141 results
Experience
|April 6, 2026
MLBPI’s Licensing Fight Ends in Victory and Settlement with DraftKings
Winston is representing MLB Players Inc. (MLBPI), which serves as the exclusive group licensing representative for all MLB (major league baseball) players. MLBPI sued several online sportsbook and mobile-betting platforms, including DraftKings, over their use of hundreds of MLB player images and likenesses without MLBPI’s consent.
Experience
|April 2, 2026
Business Combination and Secured Financing of Keo World and Maha Capital AB
Served as legal counsel to KEO World, Inc., a Miami-based fintech platform specializing in embedded credit and B2B digital payments, in connection with its business combination with Maha Capital AB, a publicly listed investment company on Nasdaq Stockholm. The transaction, which closed on April 2, 2026, was structured as a reverse triangular merger through which KEO World became a wholly owned subsidiary of Maha, with KEO World's parent entity receiving approximately 141 million newly issued Maha shares and nearly 49.2 million earn-out warrants as consideration. In connection with the closing, Maha also executed two directed capital raises totaling USD 27 million at SEK 16 per share and announced a planned third raise of USD 8 million ahead of a contemplated dual listing on a U.S. national securities exchange. Based on publicly available disclosures, the combined transaction has been valued at approximately USD 680 million.
Experience
|March 30, 2026
Winston & Strawn LLP Paris advised NextStage AM on its investment in Evoluderm, a leading French player in the hygiene and beauty sector. This growth capital transaction, led by NextStage AM as a minority investor, will provide Nathalie and Gabriel Aiach – founders and majority shareholders with over 20 years’ expertise in the cosmetics sector – with the means to accelerate their ambition: to make Evoluderm an iconic brand, ranking among the world leaders in accessible, high-quality beauty. Founded in 2004, Evoluderm has established itself over the last five years as a benchmark in the health and beauty sector, distributed in over 100 countries. The brand has thus experienced remarkable growth, with turnover tripling over the last three years to reach nearly €40 million in 2025. With the support of NextStage AM, Evoluderm is embarking on an ambitious development plan to consolidate its position as a market leader.
Insights & News 5,016 results
False Claims Act Playbook
|May 14, 2026
|3 Min Read
DOJ Launches FOCUS Initiative, Signaling Increasingly Data-Driven Era of FCA Enforcement
On April 30, 2026, the U.S. Department of Justice’s Civil Division announced a new initiative called the Fraud Oversight through Careful Use of Statistics (“FOCUS”) initiative, aimed at strengthening DOJ’s engagement with so‑called “data miner” whistleblowers who bring False Claims Act (FCA) qui tam actions based on publicly available government data, rather than insider knowledge.
In the Media
|May 13, 2026
|1 Min Read
Alexander Ott Discusses ITC Litigation Funding Disclosure Proposal with Law360
Winston & Strawn partner Alexander Ott was quoted in a Law360 article discussing the U.S. International Trade Commission (ITC)’s proposed rule requiring disclosure of litigation funding in Section 337 intellectual property investigations. The proposed rule would require parties appearing before the ITC to disclose litigation funding arrangements and entities with financial interests or authority over litigation and settlement decisions. According to the article, the ITC stated that the information could help identify conflicts of interest and provide greater clarity in Section 337 investigations.
In the Media
|May 11, 2026
|1 Min Read
Winston & Strawn partner Ben Smolij was featured in a Q&A for Bloomberg Law’s Texas Brief, where he shared insights on IPO readiness, evolving policy dynamics, and the future of capital markets in Texas.
Other Results 108 results
Law Glossary
What Is Advertising Litigation?
Advertising litigation is defined as the legal area that covers false or deceptive advertising cases. Lawsuits may be brought by government agencies or corporate competitors based on the Lanham Act—a law that specifically deals with false advertising. The Act outlines how an advertisement can be deemed false. The Federal Trade Commission (FTC) has the ability to file lawsuits to halt deceptive advertising claims. The U.S. Food and Drug Administration may also pursue advertising litigation against violators of government regulations. Companies may be called on to substantiate their advertising claims, whether these are made in print or online.
Law Glossary
What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?
There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation.